News
Pharmaceutical Technology on MSN1d
FDA approves Selarsdi injection as interchangeable with StelaraTeva Pharmaceuticals and Alvotech have announced that the US Food and Drug Administration (FDA) has approved the Selarsdi ...
Patients in the US with newly diagnosed GCA face excessive delays to initiating subcutaneous TCZ, as well high out-of-pocket costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback